For example, we observed significantly increased levels of miR-148b in SCLC compared to HBECs; miR-148b has been shown to target DNMT3B [65], with down-regulation of miR-148b observed in metastatic cancers [66]. This evidence concerns the gene DNMT3B and small cell lung carcinoma.